Home / Compliance actions / 665099

FDA Warning Letter — K.Boeun Pharmaceutical Co.,Ltd.

Case 665099 — FEI 3016756938

The FDA took a Warning Letter action against K.Boeun Pharmaceutical Co.,Ltd. on Aug 14, 2023 (Pocheon, South Korea). The action was issued by CDER and concerns drugs products.

Action Details

Facility
K.Boeun Pharmaceutical Co.,Ltd.
Date
Aug 14, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Pocheon (South Korea)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.